Login / Signup

PHOTACs enable optical control of protein degradation.

Martin ReyndersBryan S MatsuuraMarleen BéroutiDaniele SimoneschiAntonio MarzioMichele PaganoDirk H Trauner
Published in: Science advances (2020)
PROTACs (PROteolysis TArgeting Chimeras) are bifunctional molecules that target proteins for ubiquitylation by an E3 ligase complex and subsequent degradation by the proteasome. They have emerged as powerful tools to control the levels of specific cellular proteins. We now introduce photoswitchable PROTACs that can be activated with the spatiotemporal precision that light provides. These trifunctional molecules, which we named PHOTACs (PHOtochemically TArgeting Chimeras), consist of a ligand for an E3 ligase, a photoswitch, and a ligand for a protein of interest. We demonstrate this concept by using PHOTACs that target either BET family proteins (BRD2,3,4) or FKBP12. Our lead compounds display little or no activity in the dark but can be reversibly activated with different wavelengths of light. Our modular approach provides a method for the optical control of protein levels with photopharmacology and could lead to new types of precision therapeutics that avoid undesired systemic toxicity.
Keyphrases
  • protein protein
  • high resolution
  • amino acid
  • cancer therapy
  • high speed
  • oxidative stress